Smith Karen L.

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$249,995.44
Insider Sells Quantity
1
Insider Sells Sum
$44,181.63

Insider Activity of Smith Karen L.

According to the SEC Form 4 filings, Smith Karen L., being in a position of

  1. director at Aurinia Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5241 share for $44,182,
    over all time since 2024-11-11, has bought 0 shares, and sold 5241 share for $44,182.

The largest purchase of all time was on 2016-08-12 and amounted to 608 shares of Jazz Pharmaceuticals plc for $83,356.

The largest sale of all time was on 2024-11-11 and amounted to 5241 share of Aurinia Pharmaceuticals Inc. for $44,182.

Biography of Smith Karen L.

No biography is available at this moment.

2024-11-11SaleAurinia Pharmaceuticals Inc.
AUPH
director
5,241
0.0036%
$8.43$44,182+4.48%
2016-08-12PurchaseJazz Pharmaceuticals plc
JAZZ
Global Head of R&D and CMO
608
0.001%
$137.10$83,356-1.87%
2016-07-13PurchaseJazz Pharmaceuticals plc
JAZZ
Global Head of R&D and CMO
580
0.001%
$143.63$83,305-4.96%
2016-06-13PurchaseJazz Pharmaceuticals plc
JAZZ
Global Head of R&D and CMO
557
0.0009%
$149.61$83,335-9.88%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.